B. Mino

David C. Rice, Ignacio I. Wistuba, Barbara Mino, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism

Jing Wang, I. Wistuba, L. Byers, 2019, Science Translational Medicine.

Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non–Small Cell Lung Carcinoma

Jaime Rodriguez-Canales, Edwin R. Parra, Barbara Mino, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients

Jaime Rodriguez-Canales, Humam Kadara, Boris Sepesi, 2016, Clinical Cancer Research.

Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers

E. Dmitrovsky, I. Wistuba, D. Cescon, 2018, Proceedings of the National Academy of Sciences.

Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer

E. Dmitrovsky, Jing Wang, I. Wistuba, 2017, Journal of the National Cancer Institute.

Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma

I. Wistuba, J. Wargo, A. Reuben, 2016, Clinical Cancer Research.

Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity

Jing Wang, I. Wistuba, C. Creighton, 2021, Cell reports.

Immunohistochemical and Image Analysis‐Based Study Shows That Several Immune Checkpoints are Co‐expressed in Non–Small Cell Lung Carcinoma Tumors

I. Wistuba, S. Swisher, Jiexin Zhang, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

CD8+ T cells inhibit metastasis and CXCL4 regulates its function

Jeffrey T. Chang, Fei Yang, I. Wistuba, 2021, British Journal of Cancer.

Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T 790 M mutations

Jing Wang, I. Wistuba, J. Rodriguez-Canales, 2016 .

B7-H3 Expression in Merkel Cell Carcinoma–Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density

A. Rao, J. Wargo, D. Ledesma, 2019, Clinical Cancer Research.

Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma

J. Ajani, Steven H. Lin, S. Kopetz, 2019, Therapeutic advances in medical oncology.

Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy

E. Dmitrovsky, I. Wistuba, D. Cescon, 2019, Molecular Cancer Therapeutics.

Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma

J. Ajani, Steven H. Lin, M. Tetzlaff, 2019, Oncotarget.

Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer

E. Dmitrovsky, S. Hanash, I. Wistuba, 2017, Molecular Cancer Research.

CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.

E. Dmitrovsky, I. Wistuba, A. Andrew, 2015, Cancer research.

Reply to Oegema et al.: CFI-400945 and Polo-like kinase 4 inhibition

E. Dmitrovsky, I. Wistuba, D. Cescon, 2018, Proceedings of the National Academy of Sciences.